Study to Assess Pharmacokinetics, Safety, and Tolerability of MT-7117 in Subjects With Normal and Impaired Hepatic Function
Clinical trial NCT04116476 · COMPLETED
Trial details
- NCT number
- NCT04116476
- Sponsor
- Tanabe Pharma America, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-01
- Primary completion
- 2021-02-16
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.